According to Renovaro Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$41.24 Million USD, an increase over its 2022 earnings that were of -$0.11 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.